ES2055699T3 - Un procedimiento para la preparacion de nuevos derivados de eritromicilamina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de eritromicilamina.

Info

Publication number
ES2055699T3
ES2055699T3 ES87300807T ES87300807T ES2055699T3 ES 2055699 T3 ES2055699 T3 ES 2055699T3 ES 87300807 T ES87300807 T ES 87300807T ES 87300807 T ES87300807 T ES 87300807T ES 2055699 T3 ES2055699 T3 ES 2055699T3
Authority
ES
Spain
Prior art keywords
new
derivatives
erythromicilamine
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87300807T
Other languages
English (en)
Inventor
Rosanne Bonjouklian
Manuel Debono
Herbert Andrew Kirst
Julie Ann Wind
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2055699T3 publication Critical patent/ES2055699T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Mattresses And Other Support Structures For Chairs And Beds (AREA)
  • Laminated Bodies (AREA)
  • Springs (AREA)

Abstract

SE PRESENTAN NUEVOS DERIVADOS DE 9-N-SUSTITUIDOS DE LA ERITROMICILAMINA QUE TIENEN EL NUCLEO (I). ESTOS DERIVADOS PRESENTAN EXCELENTE ACTIVIDAD ORAL CONTRA LOS AGENTES PATOGENOS GRAM-POSITIVOS.
ES87300807T 1986-02-03 1987-01-29 Un procedimiento para la preparacion de nuevos derivados de eritromicilamina. Expired - Lifetime ES2055699T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82491186A 1986-02-03 1986-02-03

Publications (1)

Publication Number Publication Date
ES2055699T3 true ES2055699T3 (es) 1994-09-01

Family

ID=25242621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87300807T Expired - Lifetime ES2055699T3 (es) 1986-02-03 1987-01-29 Un procedimiento para la preparacion de nuevos derivados de eritromicilamina.

Country Status (16)

Country Link
EP (1) EP0238178B1 (es)
JP (1) JPS62185094A (es)
KR (1) KR890003844B1 (es)
CN (1) CN87100536A (es)
AT (1) ATE54151T1 (es)
AU (1) AU584270B2 (es)
CA (1) CA1265131C (es)
DE (1) DE3763413D1 (es)
DK (1) DK49487A (es)
ES (1) ES2055699T3 (es)
GR (1) GR3000647T3 (es)
HU (2) HU197023B (es)
IL (1) IL81395A0 (es)
NZ (1) NZ219083A (es)
PT (1) PT84205B (es)
ZA (1) ZA87591B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729369D0 (en) * 1987-12-16 1988-01-27 Beecham Group Plc Chemical compounds
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
DE19518917A1 (de) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
US20020132782A1 (en) * 2001-01-18 2002-09-19 Zhenkun Ma 9-amino erythromycin derivatives with antibacterial activity
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) * 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
GB1341022A (en) * 1970-04-13 1973-12-19 Lilly Industries Ltd Erythromycylamine compounds
US3681322A (en) * 1970-04-13 1972-08-01 Lilly Co Eli Adducts of aliphatic and araliphatic aldehydes and erythromycylamine or erythromycyl b amine
GB1345524A (en) * 1970-09-30 1974-01-30 Lilly Industries Ltd N-heteroarylidene erythomycylamines
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf

Also Published As

Publication number Publication date
JPS62185094A (ja) 1987-08-13
DE3763413D1 (en) 1990-08-02
CA1265131A (en) 1990-01-30
DK49487D0 (da) 1987-01-30
KR890003844B1 (ko) 1989-10-05
CN87100536A (zh) 1987-08-19
EP0238178A1 (en) 1987-09-23
HUT43086A (en) 1987-09-28
KR870007925A (ko) 1987-09-22
AU6818787A (en) 1987-08-06
GR3000647T3 (en) 1991-09-27
ATE54151T1 (de) 1990-07-15
HU201561B (en) 1990-11-28
PT84205B (pt) 1989-09-14
HU197023B (en) 1989-02-28
DK49487A (da) 1987-08-04
IL81395A0 (en) 1987-08-31
HUT50608A (en) 1990-03-28
PT84205A (en) 1987-02-01
CA1265131C (en) 1990-01-30
NZ219083A (en) 1989-08-29
ZA87591B (en) 1988-09-28
EP0238178B1 (en) 1990-06-27
AU584270B2 (en) 1989-05-18

Similar Documents

Publication Publication Date Title
NO860226L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1,4-dihydro-4-oksonaftyridin-derivater.
ES545810A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES556363A0 (es) Procedimiento para la produccion de tiazoles.,
ES546347A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES2037055T3 (es) Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas.
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES2031865T3 (es) Un procedimiento para preparar derivados de imidas.
ES555546A0 (es) Procedimiento para preparar derivados de cinalina.
ES556514A0 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
ES2055699T3 (es) Un procedimiento para la preparacion de nuevos derivados de eritromicilamina.
ES550829A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES554659A0 (es) Un procedimiento para la preparacion de derivados de piperazimilo 1,4-di sustituidos.
ES550874A0 (es) Un procedimiento para la preparacion de 3,4-dihidroxifemetilamino derivados 2-ustituidos.
EP0175266A3 (en) Antihypertensive derivatives
ES552241A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirazolopiridinas.
ES554829A0 (es) Procedimiento para preparar eteres 1,3-dioxano.
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES557625A0 (es) Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES542438A0 (es) "procedimiento para la obtencion de derivados del 2-amino- bencimidazol-n1,n'-substituidos.
ES538310A0 (es) Un procedimiento para la preparacion de derivados de 1,2,4-oxa(tia)-diazolin-3-ona.
ES554023A0 (es) Procedimiento para la produccion de derivados de acido-5-fenil carbamoil-tiobarbiturico.
NO892693L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1, 4-dihydro-4-iksonaftyridin-derivater.
ES542417A0 (es) Procedimiento para la obtencion de derivados de 2,6-dihalo- benzoilo.
ES548683A0 (es) Procedimiento de preparacion de un derivado del 2,3-dihidro-2-oxoindol

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 238178

Country of ref document: ES